Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)
China · Delayed Price · Currency is CNY 20.35
-0.03 (-0.15%)
At close: Jan 23, 2026
Cabio Biotech (Wuhan) Company Description
Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers.
It offers human and animal nutrition, personal care, and synthetic biology products. The company was founded in 1999 and is based in Wuhan, the People’s Republic of China.
Cabio Biotech (Wuhan) Co., Ltd.
| Country | China |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 565 |
| CEO | Dewei Yi |
Contact Details
Address: No. 999 Gaoxin Avenue Wuhan, 430075 China | |
| Phone | 86 27 6784 5289 |
| Website | cabio.cn |
Stock Details
| Ticker Symbol | 688089 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005X31 |
| SIC Code | 2890 |
Key Executives
| Name | Position |
|---|---|
| Dewei Yi | Chairman and GM |
| Huabiao Wang | Financial Director and Director |
| Huarong Yi | Deputy GM and Secretary of the Board of Directors |
| Anfeng Geng | Deputy General Manager |
| Xiangyu Li | Deputy General Manager |
| Hao Xiong | Accounting Supervisor |
| Zhi Bo Li | Deputy General Manager |